Clinical trial
Validation of a Molecular Prognostic Test for Eye Melanoma
NCT00406120 · Washington University School of Medicine, Other · Withdrawn
Key facts
| NCT number | NCT00406120 |
|---|---|
| Title | Validation of a Molecular Prognostic Test for Eye Melanoma |
| Official title | Validation of a Molecular Test for Predicting Metastasis in Patients With Uveal Melanoma |
| Lead sponsor | Washington University School of Medicine, Other |
| Status | Withdrawn |
| Study type | Observational |
| Conditions | Uveal Neoplasms, Choroid Neoplasms, Iris Neoplasms |
| Intervention type | Procedure |
| Interventions | Fine needle aspiration biopsy |
| Enrollment | 0 |
| Start date | May 1, 2007 |
| Primary completion | May 1, 2010 |
| Completion | May 1, 2010 |
| First posted | Dec 4, 2006 |
| Last update posted | Jun 26, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: